INDICATION
DOVATO is indicated as a complete regimen to treat HIV-1 infection in adults with no antiretroviral (ARV) treatment history or to replace the current ARV regimen in those who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable ARV regimen with no history of treatment failure and no known resistance to any component of DOVATO.
HEADLINE TITLE
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Donec finibus
For US healthcare professionals only.
DLLWCNT220009 February 2022
References:
- The INSIGHT START Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795-807. doi:10.1056/NEJMoa1506816
- Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between1 1996 and 2013: a collaborative analysis of cohort studies. Lancet. 2017;4(8):e349-e356. doi:10.1016/S2352-3018(17)30066-8
- Data on file, ViiV Healthcare.
DLLWCNT220008